4
MARKET OVERVIEW
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
5.1
PORTER'S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN EUROPE WOUND CARE MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY KEY PLAYER, 2024-2026
5.5.2
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY TYPE, 2024-2026
5.7
KEY CONFERENCES AND EVENTS (2026-2027)
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF ON EUROPE WOUND CARE MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON END-USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.5
IMPACT OF AI/GEN AI ON EUROPE WOUND CARE MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
CASE STUDIES OF AI IMPLEMENTATION
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE WOUND CARES MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
9.2
ADVANCED WOUND CARE PRODUCTS
9.2.1
ADVANCED WOUND DRESSINGS, BY TYPE
9.2.1.1.1
SILICON FOAM DRESSINGS
9.2.1.1.2
NON SILICON FOAM DRESSINGS
9.2.1.2
HYDROCOLLOID DRESSINGS
9.2.1.4
ALGINATE DRESSINGS
9.2.1.5
HYDROGEL DRESSINGS
9.2.1.6
COLLAGEN DRESSINGS
9.2.1.7
HYDROFIBER DRESSINGS
9.2.1.8
WOUND CONTACT LAYERS
9.2.1.9
SUPERABSORBENT DRESSINGS
9.2.1.10
OTHER ADVANCED WOUND CARE DRESSINGS
9.2.2
ADVANCED WOUND DRESSINGS, BY PROPERTIES
9.2.2.1
NON-ANTIMICROBIAL DRESSINGS
9.2.2.2
ANTIMICROBIAL DRESSINGS
9.2.3
DEVICES & ACCESSORIES
9.2.3.1
NPWT DEVICES & ACCESSORIES
9.2.3.2
DEBRIDEMENT DEVICES & ACCESSORIES
9.2.3.3
WOUND ASSESSMENT & MONITORING DEVICES
9.2.3.4
OTHER DEVICES & ACCESSORIES
9.2.4
BIOLOGICAL SKIN SUBSTITUTES
9.2.4.1
HUMAN DONOR TISSUE-DERIVED PRODUCTS
9.2.4.2
ACELLULAR ANIMAL-DERIVED PRODUCTS
9.2.4.3
BIOSYNTHETIC PRODUCTS
9
.3 SURGICAL WOUND CARE PRODUCTS
9.3.2
TISSUE ADHESIVES, SEALANTS, AND GLUES
9.3.2.1
FIBRIN-BASED SEALANTS
9.3.2.2
SYNTHETIC ADHESIVES
9.3.2.3
COLLAGEN-BASED SEALANTS
9.4
TRADITIONAL WOUND CARE PRODUCTS
9.4.8
OTHER TRADITIONAL WOUND CARE PRODUCTS
10
EUROPE WOUND CARES MARKET, BY WOUND TYPE (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
10.2.1
DIABETIC FOOT ULCERS
10.2.4
OTHER CHRONIC WOUNDS
10.3.1
SURGICAL & TRAUMATIC WOUNDS
11
EUROPE WOUND CARES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
11.2.1
DIABETIC FOOT ULCERS
11.4
LONG-TERM CARE FACILITIES
12
EUROPE WOUND CARE MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
13
EUROPE WOUND CARE MARKET, COMPETITIVE LANDSCAPE
13.2
KEY PLAYER STRATEGIES/RIGHT-TO-WIN
13.3
REVENUE ANALYSIS, 2021–2025
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY VALUATION & FINANCIAL METRICS
13.7
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.7.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.7.5.1
COMPANY FOOTPRINT
13.7.5.2
PRODUCT FOOTPRINT
13.7.5.3
WOUND TYPE FOOTPRINT
13.7.5.4
END USER FOOTPRINT
13.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.8.1
PROGRESSIVE COMPANIES
13.8.2
RESPONSIVE COMPANIES
13.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.9
COMPETITIVE SITUATION AND TRENDS
14
EUROPE WOUND CARE MARKET, COMPANY PROFILES
14.1.2
JOHNSON & JOHNSON SERVICES, INC. (ETHICON)
14.1.6
CONVATEC GROUP PLC
14.1.8
ORGANOGENESIS INC.
14.1.10
MIMEDEX GROUP, INC
14.1.13
ESSITY AKTIEBOLAG
14.1.14
INTEGRA LIFESCIENCES CORPORATION
14.1.15
AVERY DENNISON CORPORATION
14.1.16
MATIV HOLDINGS, INC.
14.2.1
LOHMANN & RAUSHER GMBH & CO.KG
14.2.2
MEDLINE INDUSTRIES
14.2.3
WINNER MEDICAL CO., LTD.
14.2.5
DIRECT HEALTHCARE GROUP
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.3
MARKET SIZE ESTIMATION
15.1.3.1
BOTTOM-UP APPROACH
15.1.3.2
TOP-DOWN APPROACH
15.1.3.3
BASE NUMBER CALCULATION
15.1.4
MARKET FORECAST APPROACH
15.1.5
DATA TRIANGULATION
15.1.7
RESEARCH ASSUMPTIONS
15.1.8
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Wound Care Market